iScience-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2107286, encodeId=f52e210e286f3, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：癌症生物学;肿瘤 经验分享：投稿时间节点：文章终于accept in principle了，来分享一下目前为止的时间线，供参考： 2022.8.11 投稿到Cell press community review 2022.8.17 被建议转投至iScience，8.18同意转投。 2022.8.19 完成iScience的提交并得到编辑确认，大概过了1-2天左右under review 2022.9.12 得到审稿结果，major revision 2022.11.28 修回 2022.12.6 under review 2022.12.23 all reviews complete 2022.12.24 accepted in principle 感觉整体来说审稿速度还是挺快的，我自己补实验补了两个多月，有的实验不算太顺利，但是好在审稿人也没有为难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=33, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cac51677430, createdName=马疾香幽, createdTime=Sat Dec 24 15:28:01 CST 2022, time=2022-12-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2325749, encodeId=e4fa2325e492f, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：视网膜电刺激;生物医学工程;内源性光学成像 经验分享：2025.12.22 submit 2026.2.15 major revision 2026.3.12 revised 2026.4.20 major revision 2026.5.3 revised 2026.6.4 pre-accept 2026.6.6 revised 后续再更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bd310038802, createdName=ms2000000536536677, createdTime=Fri Jun 12 16:22:15 CST 2026, time=2026-06-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2317717, encodeId=4d3f231e71708, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：自然资源管理 经验分享：投的cell旗下第一篇文章，先投的One Earth，不达标被转移至IScience 2025年开始 8.5 with editor 9.10 under review 11.11 major revision （五个审稿人，加编辑15页意见） （大修申请延迟交稿） 12.20 revision submitted to journal 12.25 with editor 2026年 1.15 under review 2.20 all reviews complete 2.25 under review 3.1 minor revision（仅审稿人1 文字排版问题、编辑问题） 3.5 with editor 3.15 under review 5.21 pre-accept 5.26 revision submitted to journal 5.27 with editor 后续再更新。据说现在AI投稿泛滥，所有审稿都在往后压, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca309338675, createdName=ms2000001718117453, createdTime=Thu May 28 16:30:29 CST 2026, time=2026-05-28, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2304259, encodeId=4d062304259dd, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：等着稿件毕业，快急死了，蜗牛一样的速度 2025.09.02：第一次投稿 2025.11.11：催稿 2025.11.26：第一次返修，大修 2025.12.26：返稿 2026.02.20：第二次返修，小修 2026.03.06：返稿 2026.03.10：accepted in principle 2026.03.12：with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65869954669, createdName=ms2000002067717582, createdTime=Thu Mar 19 10:40:53 CST 2026, time=2026-03-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2271638, encodeId=16f722e16388b, content=有没有人遇到过all reviews complete一周后又under review的啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26749575026, createdName=ms7000001521382885, createdTime=Tue Jul 01 19:13:21 CST 2025, time=2025-07-01, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2304925, encodeId=da512304925a7, content=偏重的研究方向：医学 经验分享：2026年1月12号 under review，03.24还在under review，有人遇到这么久吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04c49106938, createdName=ms7000000593949988, createdTime=Tue Mar 24 15:42:05 CST 2026, time=2026-03-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2285097, encodeId=57f1228509e32, content=怎么跟踪UR的稿件进展啊，Elsevier的公众号查不到啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=3vShNbpfOnRRZsPJLZFMhg&s=100&t=1564712332, createdBy=8bd05257114, createdName=李小二, createdTime=Fri Oct 17 11:05:01 CST 2025, time=2025-10-17, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2288537, encodeId=dd47228853e14, content=偏重的研究方向：医学综合 经验分享：投稿7天了，还是with editor，什么情况啊?焦虑啊，急啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f9ee2277466, createdName=121baaa8m66暂无昵称, createdTime=Tue Nov 11 19:27:55 CST 2025, time=2025-11-11, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2192230, encodeId=da892192230d2, content=偏重的研究方向：分子生物学 经验分享：想问下with editor 10多天了正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cb45427735, createdName=ms3000000526945160, createdTime=Sat Mar 09 14:18:13 CST 2024, time=2024-03-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2285503, encodeId=6a542285503b2, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：各位大佬，预接收改格式最后一次投回去到正式接收需要多久，现在已经一周了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=87965684663, createdName=ms4000000862769703, createdTime=Mon Oct 20 22:39:46 CST 2025, time=2025-10-20, status=1, ipAttribution=广东省)]

2022-12-24 马疾香幽来自上海

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：癌症生物学;肿瘤
经验分享：投稿时间节点：文章终于accept in principle了，来分享一下目前为止的时间线，供参考： 2022.8.11 投稿到Cell press community review 2022.8.17 被建议转投至iScience，8.18同意转投。 2022.8.19 完成iScience的提交并得到编辑确认，大概过了1-2天左右under review 2022.9.12 得到审稿结果，major revision 2022.11.28 修回 2022.12.6 under review 2022.12.23 all reviews complete 2022.12.24 accepted in principle 感觉整体来说审稿速度还是挺快的，我自己补实验补了两个多月，有的实验不算太顺利，但是好在审稿人也没有为难。

235 33 举报

展开33条回复

[GetPortalCommentsPageByObjectIdResponse(id=2107286, encodeId=f52e210e286f3, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：癌症生物学;肿瘤 经验分享：投稿时间节点：文章终于accept in principle了，来分享一下目前为止的时间线，供参考： 2022.8.11 投稿到Cell press community review 2022.8.17 被建议转投至iScience，8.18同意转投。 2022.8.19 完成iScience的提交并得到编辑确认，大概过了1-2天左右under review 2022.9.12 得到审稿结果，major revision 2022.11.28 修回 2022.12.6 under review 2022.12.23 all reviews complete 2022.12.24 accepted in principle 感觉整体来说审稿速度还是挺快的，我自己补实验补了两个多月，有的实验不算太顺利，但是好在审稿人也没有为难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=33, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cac51677430, createdName=马疾香幽, createdTime=Sat Dec 24 15:28:01 CST 2022, time=2022-12-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2325749, encodeId=e4fa2325e492f, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：视网膜电刺激;生物医学工程;内源性光学成像 经验分享：2025.12.22 submit 2026.2.15 major revision 2026.3.12 revised 2026.4.20 major revision 2026.5.3 revised 2026.6.4 pre-accept 2026.6.6 revised 后续再更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bd310038802, createdName=ms2000000536536677, createdTime=Fri Jun 12 16:22:15 CST 2026, time=2026-06-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2317717, encodeId=4d3f231e71708, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：自然资源管理 经验分享：投的cell旗下第一篇文章，先投的One Earth，不达标被转移至IScience 2025年开始 8.5 with editor 9.10 under review 11.11 major revision （五个审稿人，加编辑15页意见） （大修申请延迟交稿） 12.20 revision submitted to journal 12.25 with editor 2026年 1.15 under review 2.20 all reviews complete 2.25 under review 3.1 minor revision（仅审稿人1 文字排版问题、编辑问题） 3.5 with editor 3.15 under review 5.21 pre-accept 5.26 revision submitted to journal 5.27 with editor 后续再更新。据说现在AI投稿泛滥，所有审稿都在往后压, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca309338675, createdName=ms2000001718117453, createdTime=Thu May 28 16:30:29 CST 2026, time=2026-05-28, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2304259, encodeId=4d062304259dd, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：等着稿件毕业，快急死了，蜗牛一样的速度 2025.09.02：第一次投稿 2025.11.11：催稿 2025.11.26：第一次返修，大修 2025.12.26：返稿 2026.02.20：第二次返修，小修 2026.03.06：返稿 2026.03.10：accepted in principle 2026.03.12：with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65869954669, createdName=ms2000002067717582, createdTime=Thu Mar 19 10:40:53 CST 2026, time=2026-03-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2271638, encodeId=16f722e16388b, content=有没有人遇到过all reviews complete一周后又under review的啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26749575026, createdName=ms7000001521382885, createdTime=Tue Jul 01 19:13:21 CST 2025, time=2025-07-01, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2304925, encodeId=da512304925a7, content=偏重的研究方向：医学 经验分享：2026年1月12号 under review，03.24还在under review，有人遇到这么久吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04c49106938, createdName=ms7000000593949988, createdTime=Tue Mar 24 15:42:05 CST 2026, time=2026-03-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2285097, encodeId=57f1228509e32, content=怎么跟踪UR的稿件进展啊，Elsevier的公众号查不到啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=3vShNbpfOnRRZsPJLZFMhg&s=100&t=1564712332, createdBy=8bd05257114, createdName=李小二, createdTime=Fri Oct 17 11:05:01 CST 2025, time=2025-10-17, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2288537, encodeId=dd47228853e14, content=偏重的研究方向：医学综合 经验分享：投稿7天了，还是with editor，什么情况啊?焦虑啊，急啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f9ee2277466, createdName=121baaa8m66暂无昵称, createdTime=Tue Nov 11 19:27:55 CST 2025, time=2025-11-11, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2192230, encodeId=da892192230d2, content=偏重的研究方向：分子生物学 经验分享：想问下with editor 10多天了正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cb45427735, createdName=ms3000000526945160, createdTime=Sat Mar 09 14:18:13 CST 2024, time=2024-03-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2285503, encodeId=6a542285503b2, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：各位大佬，预接收改格式最后一次投回去到正式接收需要多久，现在已经一周了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=87965684663, createdName=ms4000000862769703, createdTime=Mon Oct 20 22:39:46 CST 2025, time=2025-10-20, status=1, ipAttribution=广东省)]

2026-06-12 ms2000000536536677 来自上海

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：视网膜电刺激;生物医学工程;内源性光学成像
经验分享：2025.12.22 submit
2026.2.15 major revision
2026.3.12 revised
2026.4.20 major revision
2026.5.3 revised
2026.6.4 pre-accept
2026.6.6 revised
后续再更新

17 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2107286, encodeId=f52e210e286f3, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：癌症生物学;肿瘤 经验分享：投稿时间节点：文章终于accept in principle了，来分享一下目前为止的时间线，供参考： 2022.8.11 投稿到Cell press community review 2022.8.17 被建议转投至iScience，8.18同意转投。 2022.8.19 完成iScience的提交并得到编辑确认，大概过了1-2天左右under review 2022.9.12 得到审稿结果，major revision 2022.11.28 修回 2022.12.6 under review 2022.12.23 all reviews complete 2022.12.24 accepted in principle 感觉整体来说审稿速度还是挺快的，我自己补实验补了两个多月，有的实验不算太顺利，但是好在审稿人也没有为难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=33, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cac51677430, createdName=马疾香幽, createdTime=Sat Dec 24 15:28:01 CST 2022, time=2022-12-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2325749, encodeId=e4fa2325e492f, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：视网膜电刺激;生物医学工程;内源性光学成像 经验分享：2025.12.22 submit 2026.2.15 major revision 2026.3.12 revised 2026.4.20 major revision 2026.5.3 revised 2026.6.4 pre-accept 2026.6.6 revised 后续再更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bd310038802, createdName=ms2000000536536677, createdTime=Fri Jun 12 16:22:15 CST 2026, time=2026-06-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2317717, encodeId=4d3f231e71708, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：自然资源管理 经验分享：投的cell旗下第一篇文章，先投的One Earth，不达标被转移至IScience 2025年开始 8.5 with editor 9.10 under review 11.11 major revision （五个审稿人，加编辑15页意见） （大修申请延迟交稿） 12.20 revision submitted to journal 12.25 with editor 2026年 1.15 under review 2.20 all reviews complete 2.25 under review 3.1 minor revision（仅审稿人1 文字排版问题、编辑问题） 3.5 with editor 3.15 under review 5.21 pre-accept 5.26 revision submitted to journal 5.27 with editor 后续再更新。据说现在AI投稿泛滥，所有审稿都在往后压, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca309338675, createdName=ms2000001718117453, createdTime=Thu May 28 16:30:29 CST 2026, time=2026-05-28, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2304259, encodeId=4d062304259dd, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：等着稿件毕业，快急死了，蜗牛一样的速度 2025.09.02：第一次投稿 2025.11.11：催稿 2025.11.26：第一次返修，大修 2025.12.26：返稿 2026.02.20：第二次返修，小修 2026.03.06：返稿 2026.03.10：accepted in principle 2026.03.12：with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65869954669, createdName=ms2000002067717582, createdTime=Thu Mar 19 10:40:53 CST 2026, time=2026-03-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2271638, encodeId=16f722e16388b, content=有没有人遇到过all reviews complete一周后又under review的啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26749575026, createdName=ms7000001521382885, createdTime=Tue Jul 01 19:13:21 CST 2025, time=2025-07-01, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2304925, encodeId=da512304925a7, content=偏重的研究方向：医学 经验分享：2026年1月12号 under review，03.24还在under review，有人遇到这么久吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04c49106938, createdName=ms7000000593949988, createdTime=Tue Mar 24 15:42:05 CST 2026, time=2026-03-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2285097, encodeId=57f1228509e32, content=怎么跟踪UR的稿件进展啊，Elsevier的公众号查不到啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=3vShNbpfOnRRZsPJLZFMhg&s=100&t=1564712332, createdBy=8bd05257114, createdName=李小二, createdTime=Fri Oct 17 11:05:01 CST 2025, time=2025-10-17, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2288537, encodeId=dd47228853e14, content=偏重的研究方向：医学综合 经验分享：投稿7天了，还是with editor，什么情况啊?焦虑啊，急啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f9ee2277466, createdName=121baaa8m66暂无昵称, createdTime=Tue Nov 11 19:27:55 CST 2025, time=2025-11-11, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2192230, encodeId=da892192230d2, content=偏重的研究方向：分子生物学 经验分享：想问下with editor 10多天了正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cb45427735, createdName=ms3000000526945160, createdTime=Sat Mar 09 14:18:13 CST 2024, time=2024-03-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2285503, encodeId=6a542285503b2, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：各位大佬，预接收改格式最后一次投回去到正式接收需要多久，现在已经一周了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=87965684663, createdName=ms4000000862769703, createdTime=Mon Oct 20 22:39:46 CST 2025, time=2025-10-20, status=1, ipAttribution=广东省)]

2026-05-28 ms2000001718117453 来自新疆

审稿速度:12.0 | 投稿命中率:75.0
偏重的研究方向：自然资源管理
经验分享：投的cell旗下第一篇文章，先投的One Earth，不达标被转移至IScience
2025年开始
8.5 with editor
9.10 under review
11.11 major revision （五个审稿人，加编辑15页意见）
（大修申请延迟交稿）
12.20 revision submitted to journal
12.25 with editor
2026年
1.15 under review
2.20 all reviews complete
2.25 under review
3.1 minor revision（仅审稿人1 文字排版问题、编辑问题）
3.5 with editor
3.15 under review
5.21 pre-accept
5.26 revision submitted to journal
5.27 with editor
后续再更新。据说现在AI投稿泛滥，所有审稿都在往后压

12 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2107286, encodeId=f52e210e286f3, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：癌症生物学;肿瘤 经验分享：投稿时间节点：文章终于accept in principle了，来分享一下目前为止的时间线，供参考： 2022.8.11 投稿到Cell press community review 2022.8.17 被建议转投至iScience，8.18同意转投。 2022.8.19 完成iScience的提交并得到编辑确认，大概过了1-2天左右under review 2022.9.12 得到审稿结果，major revision 2022.11.28 修回 2022.12.6 under review 2022.12.23 all reviews complete 2022.12.24 accepted in principle 感觉整体来说审稿速度还是挺快的，我自己补实验补了两个多月，有的实验不算太顺利，但是好在审稿人也没有为难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=33, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cac51677430, createdName=马疾香幽, createdTime=Sat Dec 24 15:28:01 CST 2022, time=2022-12-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2325749, encodeId=e4fa2325e492f, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：视网膜电刺激;生物医学工程;内源性光学成像 经验分享：2025.12.22 submit 2026.2.15 major revision 2026.3.12 revised 2026.4.20 major revision 2026.5.3 revised 2026.6.4 pre-accept 2026.6.6 revised 后续再更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bd310038802, createdName=ms2000000536536677, createdTime=Fri Jun 12 16:22:15 CST 2026, time=2026-06-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2317717, encodeId=4d3f231e71708, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：自然资源管理 经验分享：投的cell旗下第一篇文章，先投的One Earth，不达标被转移至IScience 2025年开始 8.5 with editor 9.10 under review 11.11 major revision （五个审稿人，加编辑15页意见） （大修申请延迟交稿） 12.20 revision submitted to journal 12.25 with editor 2026年 1.15 under review 2.20 all reviews complete 2.25 under review 3.1 minor revision（仅审稿人1 文字排版问题、编辑问题） 3.5 with editor 3.15 under review 5.21 pre-accept 5.26 revision submitted to journal 5.27 with editor 后续再更新。据说现在AI投稿泛滥，所有审稿都在往后压, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca309338675, createdName=ms2000001718117453, createdTime=Thu May 28 16:30:29 CST 2026, time=2026-05-28, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2304259, encodeId=4d062304259dd, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：等着稿件毕业，快急死了，蜗牛一样的速度 2025.09.02：第一次投稿 2025.11.11：催稿 2025.11.26：第一次返修，大修 2025.12.26：返稿 2026.02.20：第二次返修，小修 2026.03.06：返稿 2026.03.10：accepted in principle 2026.03.12：with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65869954669, createdName=ms2000002067717582, createdTime=Thu Mar 19 10:40:53 CST 2026, time=2026-03-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2271638, encodeId=16f722e16388b, content=有没有人遇到过all reviews complete一周后又under review的啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26749575026, createdName=ms7000001521382885, createdTime=Tue Jul 01 19:13:21 CST 2025, time=2025-07-01, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2304925, encodeId=da512304925a7, content=偏重的研究方向：医学 经验分享：2026年1月12号 under review，03.24还在under review，有人遇到这么久吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04c49106938, createdName=ms7000000593949988, createdTime=Tue Mar 24 15:42:05 CST 2026, time=2026-03-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2285097, encodeId=57f1228509e32, content=怎么跟踪UR的稿件进展啊，Elsevier的公众号查不到啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=3vShNbpfOnRRZsPJLZFMhg&s=100&t=1564712332, createdBy=8bd05257114, createdName=李小二, createdTime=Fri Oct 17 11:05:01 CST 2025, time=2025-10-17, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2288537, encodeId=dd47228853e14, content=偏重的研究方向：医学综合 经验分享：投稿7天了，还是with editor，什么情况啊?焦虑啊，急啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f9ee2277466, createdName=121baaa8m66暂无昵称, createdTime=Tue Nov 11 19:27:55 CST 2025, time=2025-11-11, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2192230, encodeId=da892192230d2, content=偏重的研究方向：分子生物学 经验分享：想问下with editor 10多天了正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cb45427735, createdName=ms3000000526945160, createdTime=Sat Mar 09 14:18:13 CST 2024, time=2024-03-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2285503, encodeId=6a542285503b2, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：各位大佬，预接收改格式最后一次投回去到正式接收需要多久，现在已经一周了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=87965684663, createdName=ms4000000862769703, createdTime=Mon Oct 20 22:39:46 CST 2025, time=2025-10-20, status=1, ipAttribution=广东省)]

2026-03-19 ms2000002067717582 来自广东省

审稿速度:6.0 | 投稿命中率:50.0
经验分享：等着稿件毕业，快急死了，蜗牛一样的速度

2025.09.02：第一次投稿
2025.11.11：催稿
2025.11.26：第一次返修，大修
2025.12.26：返稿
2026.02.20：第二次返修，小修
2026.03.06：返稿
2026.03.10：accepted in principle
2026.03.12：with editor

68 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2107286, encodeId=f52e210e286f3, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：癌症生物学;肿瘤 经验分享：投稿时间节点：文章终于accept in principle了，来分享一下目前为止的时间线，供参考： 2022.8.11 投稿到Cell press community review 2022.8.17 被建议转投至iScience，8.18同意转投。 2022.8.19 完成iScience的提交并得到编辑确认，大概过了1-2天左右under review 2022.9.12 得到审稿结果，major revision 2022.11.28 修回 2022.12.6 under review 2022.12.23 all reviews complete 2022.12.24 accepted in principle 感觉整体来说审稿速度还是挺快的，我自己补实验补了两个多月，有的实验不算太顺利，但是好在审稿人也没有为难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=33, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cac51677430, createdName=马疾香幽, createdTime=Sat Dec 24 15:28:01 CST 2022, time=2022-12-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2325749, encodeId=e4fa2325e492f, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：视网膜电刺激;生物医学工程;内源性光学成像 经验分享：2025.12.22 submit 2026.2.15 major revision 2026.3.12 revised 2026.4.20 major revision 2026.5.3 revised 2026.6.4 pre-accept 2026.6.6 revised 后续再更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bd310038802, createdName=ms2000000536536677, createdTime=Fri Jun 12 16:22:15 CST 2026, time=2026-06-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2317717, encodeId=4d3f231e71708, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：自然资源管理 经验分享：投的cell旗下第一篇文章，先投的One Earth，不达标被转移至IScience 2025年开始 8.5 with editor 9.10 under review 11.11 major revision （五个审稿人，加编辑15页意见） （大修申请延迟交稿） 12.20 revision submitted to journal 12.25 with editor 2026年 1.15 under review 2.20 all reviews complete 2.25 under review 3.1 minor revision（仅审稿人1 文字排版问题、编辑问题） 3.5 with editor 3.15 under review 5.21 pre-accept 5.26 revision submitted to journal 5.27 with editor 后续再更新。据说现在AI投稿泛滥，所有审稿都在往后压, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca309338675, createdName=ms2000001718117453, createdTime=Thu May 28 16:30:29 CST 2026, time=2026-05-28, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2304259, encodeId=4d062304259dd, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：等着稿件毕业，快急死了，蜗牛一样的速度 2025.09.02：第一次投稿 2025.11.11：催稿 2025.11.26：第一次返修，大修 2025.12.26：返稿 2026.02.20：第二次返修，小修 2026.03.06：返稿 2026.03.10：accepted in principle 2026.03.12：with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65869954669, createdName=ms2000002067717582, createdTime=Thu Mar 19 10:40:53 CST 2026, time=2026-03-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2271638, encodeId=16f722e16388b, content=有没有人遇到过all reviews complete一周后又under review的啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26749575026, createdName=ms7000001521382885, createdTime=Tue Jul 01 19:13:21 CST 2025, time=2025-07-01, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2304925, encodeId=da512304925a7, content=偏重的研究方向：医学 经验分享：2026年1月12号 under review，03.24还在under review，有人遇到这么久吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04c49106938, createdName=ms7000000593949988, createdTime=Tue Mar 24 15:42:05 CST 2026, time=2026-03-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2285097, encodeId=57f1228509e32, content=怎么跟踪UR的稿件进展啊，Elsevier的公众号查不到啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=3vShNbpfOnRRZsPJLZFMhg&s=100&t=1564712332, createdBy=8bd05257114, createdName=李小二, createdTime=Fri Oct 17 11:05:01 CST 2025, time=2025-10-17, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2288537, encodeId=dd47228853e14, content=偏重的研究方向：医学综合 经验分享：投稿7天了，还是with editor，什么情况啊?焦虑啊，急啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f9ee2277466, createdName=121baaa8m66暂无昵称, createdTime=Tue Nov 11 19:27:55 CST 2025, time=2025-11-11, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2192230, encodeId=da892192230d2, content=偏重的研究方向：分子生物学 经验分享：想问下with editor 10多天了正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cb45427735, createdName=ms3000000526945160, createdTime=Sat Mar 09 14:18:13 CST 2024, time=2024-03-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2285503, encodeId=6a542285503b2, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：各位大佬，预接收改格式最后一次投回去到正式接收需要多久，现在已经一周了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=87965684663, createdName=ms4000000862769703, createdTime=Mon Oct 20 22:39:46 CST 2025, time=2025-10-20, status=1, ipAttribution=广东省)]

2025-07-01 ms7000001521382885 来自北京

有没有人遇到过all reviews complete一周后又under review的啊

123 5 举报

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2107286, encodeId=f52e210e286f3, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：癌症生物学;肿瘤 经验分享：投稿时间节点：文章终于accept in principle了，来分享一下目前为止的时间线，供参考： 2022.8.11 投稿到Cell press community review 2022.8.17 被建议转投至iScience，8.18同意转投。 2022.8.19 完成iScience的提交并得到编辑确认，大概过了1-2天左右under review 2022.9.12 得到审稿结果，major revision 2022.11.28 修回 2022.12.6 under review 2022.12.23 all reviews complete 2022.12.24 accepted in principle 感觉整体来说审稿速度还是挺快的，我自己补实验补了两个多月，有的实验不算太顺利，但是好在审稿人也没有为难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=33, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cac51677430, createdName=马疾香幽, createdTime=Sat Dec 24 15:28:01 CST 2022, time=2022-12-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2325749, encodeId=e4fa2325e492f, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：视网膜电刺激;生物医学工程;内源性光学成像 经验分享：2025.12.22 submit 2026.2.15 major revision 2026.3.12 revised 2026.4.20 major revision 2026.5.3 revised 2026.6.4 pre-accept 2026.6.6 revised 后续再更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bd310038802, createdName=ms2000000536536677, createdTime=Fri Jun 12 16:22:15 CST 2026, time=2026-06-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2317717, encodeId=4d3f231e71708, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：自然资源管理 经验分享：投的cell旗下第一篇文章，先投的One Earth，不达标被转移至IScience 2025年开始 8.5 with editor 9.10 under review 11.11 major revision （五个审稿人，加编辑15页意见） （大修申请延迟交稿） 12.20 revision submitted to journal 12.25 with editor 2026年 1.15 under review 2.20 all reviews complete 2.25 under review 3.1 minor revision（仅审稿人1 文字排版问题、编辑问题） 3.5 with editor 3.15 under review 5.21 pre-accept 5.26 revision submitted to journal 5.27 with editor 后续再更新。据说现在AI投稿泛滥，所有审稿都在往后压, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca309338675, createdName=ms2000001718117453, createdTime=Thu May 28 16:30:29 CST 2026, time=2026-05-28, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2304259, encodeId=4d062304259dd, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：等着稿件毕业，快急死了，蜗牛一样的速度 2025.09.02：第一次投稿 2025.11.11：催稿 2025.11.26：第一次返修，大修 2025.12.26：返稿 2026.02.20：第二次返修，小修 2026.03.06：返稿 2026.03.10：accepted in principle 2026.03.12：with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65869954669, createdName=ms2000002067717582, createdTime=Thu Mar 19 10:40:53 CST 2026, time=2026-03-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2271638, encodeId=16f722e16388b, content=有没有人遇到过all reviews complete一周后又under review的啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26749575026, createdName=ms7000001521382885, createdTime=Tue Jul 01 19:13:21 CST 2025, time=2025-07-01, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2304925, encodeId=da512304925a7, content=偏重的研究方向：医学 经验分享：2026年1月12号 under review，03.24还在under review，有人遇到这么久吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04c49106938, createdName=ms7000000593949988, createdTime=Tue Mar 24 15:42:05 CST 2026, time=2026-03-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2285097, encodeId=57f1228509e32, content=怎么跟踪UR的稿件进展啊，Elsevier的公众号查不到啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=3vShNbpfOnRRZsPJLZFMhg&s=100&t=1564712332, createdBy=8bd05257114, createdName=李小二, createdTime=Fri Oct 17 11:05:01 CST 2025, time=2025-10-17, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2288537, encodeId=dd47228853e14, content=偏重的研究方向：医学综合 经验分享：投稿7天了，还是with editor，什么情况啊?焦虑啊，急啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f9ee2277466, createdName=121baaa8m66暂无昵称, createdTime=Tue Nov 11 19:27:55 CST 2025, time=2025-11-11, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2192230, encodeId=da892192230d2, content=偏重的研究方向：分子生物学 经验分享：想问下with editor 10多天了正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cb45427735, createdName=ms3000000526945160, createdTime=Sat Mar 09 14:18:13 CST 2024, time=2024-03-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2285503, encodeId=6a542285503b2, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：各位大佬，预接收改格式最后一次投回去到正式接收需要多久，现在已经一周了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=87965684663, createdName=ms4000000862769703, createdTime=Mon Oct 20 22:39:46 CST 2025, time=2025-10-20, status=1, ipAttribution=广东省)]

2026-03-24 ms7000000593949988 来自广东省

偏重的研究方向：医学
经验分享：2026年1月12号 under review，03.24还在under review，有人遇到这么久吗

46 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2107286, encodeId=f52e210e286f3, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：癌症生物学;肿瘤 经验分享：投稿时间节点：文章终于accept in principle了，来分享一下目前为止的时间线，供参考： 2022.8.11 投稿到Cell press community review 2022.8.17 被建议转投至iScience，8.18同意转投。 2022.8.19 完成iScience的提交并得到编辑确认，大概过了1-2天左右under review 2022.9.12 得到审稿结果，major revision 2022.11.28 修回 2022.12.6 under review 2022.12.23 all reviews complete 2022.12.24 accepted in principle 感觉整体来说审稿速度还是挺快的，我自己补实验补了两个多月，有的实验不算太顺利，但是好在审稿人也没有为难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=33, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cac51677430, createdName=马疾香幽, createdTime=Sat Dec 24 15:28:01 CST 2022, time=2022-12-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2325749, encodeId=e4fa2325e492f, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：视网膜电刺激;生物医学工程;内源性光学成像 经验分享：2025.12.22 submit 2026.2.15 major revision 2026.3.12 revised 2026.4.20 major revision 2026.5.3 revised 2026.6.4 pre-accept 2026.6.6 revised 后续再更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bd310038802, createdName=ms2000000536536677, createdTime=Fri Jun 12 16:22:15 CST 2026, time=2026-06-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2317717, encodeId=4d3f231e71708, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：自然资源管理 经验分享：投的cell旗下第一篇文章，先投的One Earth，不达标被转移至IScience 2025年开始 8.5 with editor 9.10 under review 11.11 major revision （五个审稿人，加编辑15页意见） （大修申请延迟交稿） 12.20 revision submitted to journal 12.25 with editor 2026年 1.15 under review 2.20 all reviews complete 2.25 under review 3.1 minor revision（仅审稿人1 文字排版问题、编辑问题） 3.5 with editor 3.15 under review 5.21 pre-accept 5.26 revision submitted to journal 5.27 with editor 后续再更新。据说现在AI投稿泛滥，所有审稿都在往后压, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca309338675, createdName=ms2000001718117453, createdTime=Thu May 28 16:30:29 CST 2026, time=2026-05-28, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2304259, encodeId=4d062304259dd, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：等着稿件毕业，快急死了，蜗牛一样的速度 2025.09.02：第一次投稿 2025.11.11：催稿 2025.11.26：第一次返修，大修 2025.12.26：返稿 2026.02.20：第二次返修，小修 2026.03.06：返稿 2026.03.10：accepted in principle 2026.03.12：with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65869954669, createdName=ms2000002067717582, createdTime=Thu Mar 19 10:40:53 CST 2026, time=2026-03-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2271638, encodeId=16f722e16388b, content=有没有人遇到过all reviews complete一周后又under review的啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26749575026, createdName=ms7000001521382885, createdTime=Tue Jul 01 19:13:21 CST 2025, time=2025-07-01, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2304925, encodeId=da512304925a7, content=偏重的研究方向：医学 经验分享：2026年1月12号 under review，03.24还在under review，有人遇到这么久吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04c49106938, createdName=ms7000000593949988, createdTime=Tue Mar 24 15:42:05 CST 2026, time=2026-03-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2285097, encodeId=57f1228509e32, content=怎么跟踪UR的稿件进展啊，Elsevier的公众号查不到啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=3vShNbpfOnRRZsPJLZFMhg&s=100&t=1564712332, createdBy=8bd05257114, createdName=李小二, createdTime=Fri Oct 17 11:05:01 CST 2025, time=2025-10-17, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2288537, encodeId=dd47228853e14, content=偏重的研究方向：医学综合 经验分享：投稿7天了，还是with editor，什么情况啊?焦虑啊，急啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f9ee2277466, createdName=121baaa8m66暂无昵称, createdTime=Tue Nov 11 19:27:55 CST 2025, time=2025-11-11, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2192230, encodeId=da892192230d2, content=偏重的研究方向：分子生物学 经验分享：想问下with editor 10多天了正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cb45427735, createdName=ms3000000526945160, createdTime=Sat Mar 09 14:18:13 CST 2024, time=2024-03-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2285503, encodeId=6a542285503b2, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：各位大佬，预接收改格式最后一次投回去到正式接收需要多久，现在已经一周了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=87965684663, createdName=ms4000000862769703, createdTime=Mon Oct 20 22:39:46 CST 2025, time=2025-10-20, status=1, ipAttribution=广东省)]

2025-10-17 李小二来自浙江省

怎么跟踪UR的稿件进展啊，Elsevier的公众号查不到啊

90 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2107286, encodeId=f52e210e286f3, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：癌症生物学;肿瘤 经验分享：投稿时间节点：文章终于accept in principle了，来分享一下目前为止的时间线，供参考： 2022.8.11 投稿到Cell press community review 2022.8.17 被建议转投至iScience，8.18同意转投。 2022.8.19 完成iScience的提交并得到编辑确认，大概过了1-2天左右under review 2022.9.12 得到审稿结果，major revision 2022.11.28 修回 2022.12.6 under review 2022.12.23 all reviews complete 2022.12.24 accepted in principle 感觉整体来说审稿速度还是挺快的，我自己补实验补了两个多月，有的实验不算太顺利，但是好在审稿人也没有为难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=33, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cac51677430, createdName=马疾香幽, createdTime=Sat Dec 24 15:28:01 CST 2022, time=2022-12-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2325749, encodeId=e4fa2325e492f, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：视网膜电刺激;生物医学工程;内源性光学成像 经验分享：2025.12.22 submit 2026.2.15 major revision 2026.3.12 revised 2026.4.20 major revision 2026.5.3 revised 2026.6.4 pre-accept 2026.6.6 revised 后续再更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bd310038802, createdName=ms2000000536536677, createdTime=Fri Jun 12 16:22:15 CST 2026, time=2026-06-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2317717, encodeId=4d3f231e71708, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：自然资源管理 经验分享：投的cell旗下第一篇文章，先投的One Earth，不达标被转移至IScience 2025年开始 8.5 with editor 9.10 under review 11.11 major revision （五个审稿人，加编辑15页意见） （大修申请延迟交稿） 12.20 revision submitted to journal 12.25 with editor 2026年 1.15 under review 2.20 all reviews complete 2.25 under review 3.1 minor revision（仅审稿人1 文字排版问题、编辑问题） 3.5 with editor 3.15 under review 5.21 pre-accept 5.26 revision submitted to journal 5.27 with editor 后续再更新。据说现在AI投稿泛滥，所有审稿都在往后压, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca309338675, createdName=ms2000001718117453, createdTime=Thu May 28 16:30:29 CST 2026, time=2026-05-28, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2304259, encodeId=4d062304259dd, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：等着稿件毕业，快急死了，蜗牛一样的速度 2025.09.02：第一次投稿 2025.11.11：催稿 2025.11.26：第一次返修，大修 2025.12.26：返稿 2026.02.20：第二次返修，小修 2026.03.06：返稿 2026.03.10：accepted in principle 2026.03.12：with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65869954669, createdName=ms2000002067717582, createdTime=Thu Mar 19 10:40:53 CST 2026, time=2026-03-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2271638, encodeId=16f722e16388b, content=有没有人遇到过all reviews complete一周后又under review的啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26749575026, createdName=ms7000001521382885, createdTime=Tue Jul 01 19:13:21 CST 2025, time=2025-07-01, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2304925, encodeId=da512304925a7, content=偏重的研究方向：医学 经验分享：2026年1月12号 under review，03.24还在under review，有人遇到这么久吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04c49106938, createdName=ms7000000593949988, createdTime=Tue Mar 24 15:42:05 CST 2026, time=2026-03-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2285097, encodeId=57f1228509e32, content=怎么跟踪UR的稿件进展啊，Elsevier的公众号查不到啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=3vShNbpfOnRRZsPJLZFMhg&s=100&t=1564712332, createdBy=8bd05257114, createdName=李小二, createdTime=Fri Oct 17 11:05:01 CST 2025, time=2025-10-17, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2288537, encodeId=dd47228853e14, content=偏重的研究方向：医学综合 经验分享：投稿7天了，还是with editor，什么情况啊?焦虑啊，急啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f9ee2277466, createdName=121baaa8m66暂无昵称, createdTime=Tue Nov 11 19:27:55 CST 2025, time=2025-11-11, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2192230, encodeId=da892192230d2, content=偏重的研究方向：分子生物学 经验分享：想问下with editor 10多天了正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cb45427735, createdName=ms3000000526945160, createdTime=Sat Mar 09 14:18:13 CST 2024, time=2024-03-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2285503, encodeId=6a542285503b2, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：各位大佬，预接收改格式最后一次投回去到正式接收需要多久，现在已经一周了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=87965684663, createdName=ms4000000862769703, createdTime=Mon Oct 20 22:39:46 CST 2025, time=2025-10-20, status=1, ipAttribution=广东省)]

2025-11-11 121baaa8m66暂无昵称来自福建省

偏重的研究方向：医学综合
经验分享：投稿7天了，还是with editor，什么情况啊?焦虑啊，急啊

75 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2107286, encodeId=f52e210e286f3, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：癌症生物学;肿瘤 经验分享：投稿时间节点：文章终于accept in principle了，来分享一下目前为止的时间线，供参考： 2022.8.11 投稿到Cell press community review 2022.8.17 被建议转投至iScience，8.18同意转投。 2022.8.19 完成iScience的提交并得到编辑确认，大概过了1-2天左右under review 2022.9.12 得到审稿结果，major revision 2022.11.28 修回 2022.12.6 under review 2022.12.23 all reviews complete 2022.12.24 accepted in principle 感觉整体来说审稿速度还是挺快的，我自己补实验补了两个多月，有的实验不算太顺利，但是好在审稿人也没有为难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=33, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cac51677430, createdName=马疾香幽, createdTime=Sat Dec 24 15:28:01 CST 2022, time=2022-12-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2325749, encodeId=e4fa2325e492f, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：视网膜电刺激;生物医学工程;内源性光学成像 经验分享：2025.12.22 submit 2026.2.15 major revision 2026.3.12 revised 2026.4.20 major revision 2026.5.3 revised 2026.6.4 pre-accept 2026.6.6 revised 后续再更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bd310038802, createdName=ms2000000536536677, createdTime=Fri Jun 12 16:22:15 CST 2026, time=2026-06-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2317717, encodeId=4d3f231e71708, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：自然资源管理 经验分享：投的cell旗下第一篇文章，先投的One Earth，不达标被转移至IScience 2025年开始 8.5 with editor 9.10 under review 11.11 major revision （五个审稿人，加编辑15页意见） （大修申请延迟交稿） 12.20 revision submitted to journal 12.25 with editor 2026年 1.15 under review 2.20 all reviews complete 2.25 under review 3.1 minor revision（仅审稿人1 文字排版问题、编辑问题） 3.5 with editor 3.15 under review 5.21 pre-accept 5.26 revision submitted to journal 5.27 with editor 后续再更新。据说现在AI投稿泛滥，所有审稿都在往后压, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca309338675, createdName=ms2000001718117453, createdTime=Thu May 28 16:30:29 CST 2026, time=2026-05-28, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2304259, encodeId=4d062304259dd, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：等着稿件毕业，快急死了，蜗牛一样的速度 2025.09.02：第一次投稿 2025.11.11：催稿 2025.11.26：第一次返修，大修 2025.12.26：返稿 2026.02.20：第二次返修，小修 2026.03.06：返稿 2026.03.10：accepted in principle 2026.03.12：with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65869954669, createdName=ms2000002067717582, createdTime=Thu Mar 19 10:40:53 CST 2026, time=2026-03-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2271638, encodeId=16f722e16388b, content=有没有人遇到过all reviews complete一周后又under review的啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26749575026, createdName=ms7000001521382885, createdTime=Tue Jul 01 19:13:21 CST 2025, time=2025-07-01, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2304925, encodeId=da512304925a7, content=偏重的研究方向：医学 经验分享：2026年1月12号 under review，03.24还在under review，有人遇到这么久吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04c49106938, createdName=ms7000000593949988, createdTime=Tue Mar 24 15:42:05 CST 2026, time=2026-03-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2285097, encodeId=57f1228509e32, content=怎么跟踪UR的稿件进展啊，Elsevier的公众号查不到啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=3vShNbpfOnRRZsPJLZFMhg&s=100&t=1564712332, createdBy=8bd05257114, createdName=李小二, createdTime=Fri Oct 17 11:05:01 CST 2025, time=2025-10-17, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2288537, encodeId=dd47228853e14, content=偏重的研究方向：医学综合 经验分享：投稿7天了，还是with editor，什么情况啊?焦虑啊，急啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f9ee2277466, createdName=121baaa8m66暂无昵称, createdTime=Tue Nov 11 19:27:55 CST 2025, time=2025-11-11, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2192230, encodeId=da892192230d2, content=偏重的研究方向：分子生物学 经验分享：想问下with editor 10多天了正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cb45427735, createdName=ms3000000526945160, createdTime=Sat Mar 09 14:18:13 CST 2024, time=2024-03-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2285503, encodeId=6a542285503b2, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：各位大佬，预接收改格式最后一次投回去到正式接收需要多久，现在已经一周了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=87965684663, createdName=ms4000000862769703, createdTime=Mon Oct 20 22:39:46 CST 2025, time=2025-10-20, status=1, ipAttribution=广东省)]

2024-03-09 ms3000000526945160 来自湖北省

偏重的研究方向：分子生物学
经验分享：想问下with editor 10多天了正常吗

152 6 举报

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2107286, encodeId=f52e210e286f3, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：癌症生物学;肿瘤 经验分享：投稿时间节点：文章终于accept in principle了，来分享一下目前为止的时间线，供参考： 2022.8.11 投稿到Cell press community review 2022.8.17 被建议转投至iScience，8.18同意转投。 2022.8.19 完成iScience的提交并得到编辑确认，大概过了1-2天左右under review 2022.9.12 得到审稿结果，major revision 2022.11.28 修回 2022.12.6 under review 2022.12.23 all reviews complete 2022.12.24 accepted in principle 感觉整体来说审稿速度还是挺快的，我自己补实验补了两个多月，有的实验不算太顺利，但是好在审稿人也没有为难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=33, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cac51677430, createdName=马疾香幽, createdTime=Sat Dec 24 15:28:01 CST 2022, time=2022-12-24, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2325749, encodeId=e4fa2325e492f, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：视网膜电刺激;生物医学工程;内源性光学成像 经验分享：2025.12.22 submit 2026.2.15 major revision 2026.3.12 revised 2026.4.20 major revision 2026.5.3 revised 2026.6.4 pre-accept 2026.6.6 revised 后续再更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bd310038802, createdName=ms2000000536536677, createdTime=Fri Jun 12 16:22:15 CST 2026, time=2026-06-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2317717, encodeId=4d3f231e71708, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：自然资源管理 经验分享：投的cell旗下第一篇文章，先投的One Earth，不达标被转移至IScience 2025年开始 8.5 with editor 9.10 under review 11.11 major revision （五个审稿人，加编辑15页意见） （大修申请延迟交稿） 12.20 revision submitted to journal 12.25 with editor 2026年 1.15 under review 2.20 all reviews complete 2.25 under review 3.1 minor revision（仅审稿人1 文字排版问题、编辑问题） 3.5 with editor 3.15 under review 5.21 pre-accept 5.26 revision submitted to journal 5.27 with editor 后续再更新。据说现在AI投稿泛滥，所有审稿都在往后压, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca309338675, createdName=ms2000001718117453, createdTime=Thu May 28 16:30:29 CST 2026, time=2026-05-28, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2304259, encodeId=4d062304259dd, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：等着稿件毕业，快急死了，蜗牛一样的速度 2025.09.02：第一次投稿 2025.11.11：催稿 2025.11.26：第一次返修，大修 2025.12.26：返稿 2026.02.20：第二次返修，小修 2026.03.06：返稿 2026.03.10：accepted in principle 2026.03.12：with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65869954669, createdName=ms2000002067717582, createdTime=Thu Mar 19 10:40:53 CST 2026, time=2026-03-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2271638, encodeId=16f722e16388b, content=有没有人遇到过all reviews complete一周后又under review的啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26749575026, createdName=ms7000001521382885, createdTime=Tue Jul 01 19:13:21 CST 2025, time=2025-07-01, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2304925, encodeId=da512304925a7, content=偏重的研究方向：医学 经验分享：2026年1月12号 under review，03.24还在under review，有人遇到这么久吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04c49106938, createdName=ms7000000593949988, createdTime=Tue Mar 24 15:42:05 CST 2026, time=2026-03-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2285097, encodeId=57f1228509e32, content=怎么跟踪UR的稿件进展啊，Elsevier的公众号查不到啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=3vShNbpfOnRRZsPJLZFMhg&s=100&t=1564712332, createdBy=8bd05257114, createdName=李小二, createdTime=Fri Oct 17 11:05:01 CST 2025, time=2025-10-17, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2288537, encodeId=dd47228853e14, content=偏重的研究方向：医学综合 经验分享：投稿7天了，还是with editor，什么情况啊?焦虑啊，急啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f9ee2277466, createdName=121baaa8m66暂无昵称, createdTime=Tue Nov 11 19:27:55 CST 2025, time=2025-11-11, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2192230, encodeId=da892192230d2, content=偏重的研究方向：分子生物学 经验分享：想问下with editor 10多天了正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2cb45427735, createdName=ms3000000526945160, createdTime=Sat Mar 09 14:18:13 CST 2024, time=2024-03-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2285503, encodeId=6a542285503b2, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：各位大佬，预接收改格式最后一次投回去到正式接收需要多久，现在已经一周了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=87965684663, createdName=ms4000000862769703, createdTime=Mon Oct 20 22:39:46 CST 2025, time=2025-10-20, status=1, ipAttribution=广东省)]

2025-10-20 ms4000000862769703 来自广东省

审稿速度:3.0 | 投稿命中率:75.0
经验分享：各位大佬，预接收改格式最后一次投回去到正式接收需要多久，现在已经一周了

93 1 举报

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务